Family Medicine · Philadelphia, PA
NPI
1386688935
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2813 Cottman Avenue
Philadelphia, PA, 19149
Phone (215) 332-9666
Groups this clinician bills Medicare through
Medicare paid, 2024
$46K
568 services
Medicare patients, 2024
134
Average age 73
Drug cost, 2024
$422K
6,506 prescriptions
Company payments, 2025
$1,182
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Sevitski was code 99213 (office e&m - established), 198 times for 108 patients. In total David J Sevitski billed 568 services in 17 codes, and Medicare paid $46K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 198 | 108 | $66.37 | $13K |
| 99214 Office E&M - Established | Office | 137 | 82 | $96.56 | $13K |
| 90662 Vaccine Product | Office | 76 | 75 | $80.35 | $6,107 |
| G0008 Administration of influenza virus vaccine | Office | 76 | 75 | $33.29 | $2,530 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 25 | 25 | $132.94 | $3,324 |
By year: 2022 $34K for 422 services; 2023 $28K for 365 services; 2024 $46K for 568 services.
Medicare prescription drug claims, 2024
In 2024, the drug David J Sevitski prescribed most often to Medicare patients was Rosuvastatin Calcium, with 446 prescriptions and refills. In total David J Sevitski wrote 6,506 Medicare prescriptions that cost $422K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 446 | 962 | 107 | $5,522 |
| Amlodipine Besylate Generic | 286 | 644 | 65 | $1,453 |
| Metformin Hcl Er Metformin Hcl | 248 | 554 | 60 | $4,490 |
| Pantoprazole Sodium Generic | 244 | 590 | 63 | $2,049 |
| Lisinopril Generic | 228 | 587 | 55 | $1,902 |
| Atorvastatin Calcium Generic | 204 | 514 | 57 | $2,968 |
| Simvastatin Generic | 199 | 507 | 52 | $2,578 |
| Hydrochlorothiazide Generic | 177 | 363 | 42 | $730 |
| Pravastatin Sodium Generic | 175 | 403 | 40 | $3,215 |
| Levothyroxine Sodium Generic | 169 | 411 | 41 | $2,400 |
| Omeprazole Generic | 147 | 343 | 34 | $1,204 |
| Sertraline Hcl Generic | 130 | 278 | 30 | $780 |
| Metoprolol Succinate Generic | 125 | 319 | 35 | $1,793 |
| Gabapentin Generic | 104 | 195 | 24 | $957 |
| Tamsulosin Hcl Generic | 99 | 169 | 18 | $674 |
Brand drugs: 584 claims; generic drugs: 5,875 claims; opioid claims: 95.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Sevitski $1,182 ($1,182 in general payments such as food, travel and fees) from 12 companies. The largest payer was Novo Nordisk Inc with $335.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 13 | $335 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $181 |
| Lilly USA, LLC LLY | 7 | $146 |
| GlaxoSmithKline, LLC. GSK | 7 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $114 |
| Abbvie Inc. ABBV | 6 | $93 |
| Exact Sciences Corporation EXAS | 3 | $56.75 |
| Pfizer Inc. PFE | 2 | $41.89 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $35.43 |
| Abbott Laboratories ABT | 1 | $24.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.